ISSN: 2639-2038
Authors: Pius M*, Adebisi YA, Muhammed Y, Oladipo O, Ejim D and Dauda AM
Since the onset of the pandemic, there have been over 200 million cases of COVID-19 cases reported and nearly 5 million deaths worldwide. The USA has been hardest hit with over 35 million cases and 713,350 deaths, followed by Brazil and India which suffered huge mortalities during the third wave. Regardless of the number of cases and consequent deaths recorded, no country has been immune to the economic downturn that the pandemic unleased, accentuating the need for widespread vaccination to reduce the impact of the virus. As at the time of writing this paper, the global vaccination stat report that 3.75 billion people have received at least a dose and 2.8 billion people are fully vaccinated worldwide. Nigeria is a developing country and like many third world countries was dependent on the developed countries for al protective equipment, test kits, as well as vaccines. The population in Nigeria has more youth than the elderly and explanation for why the cases reported were far less even with a population of over 200 million people. A little over 200,000 cases have so far been reported in Nigeria with about 2,837 deaths. An abysmally low 2.5% of the population have currently been vaccinated with only 1.1% having received both doses, owing to several reasons, and the death toll continues to count. Globally, the vaccination strategy has been to get the jabs to the most vulnerable first and then make it available to the general population. In this article, we discuss the relevance of personalized medicine in COVID-19 vaccination in a country, Nigeria, burdened with diseases comorbidity
Keywords: Population; Vaccination; Coronavirus; Pandemic; Hypertension
